- Are Dovato and Atripla the Same Thing?
- What Are Possible Side Effects of Dovato?
- What Are Possible Side Effects of Atripla?
- What Is Dovato?
- What Is Atripla?
- What Drugs Interact with Dovato?
- What Drugs Interact with Atripla?
- How Should Dovato Be Taken?
- How Should Atripla Be Taken?
Are Dovato and Atripla the Same Thing?
Atripla is used to treat acute myeloid leukemia (AML). Atripla is usually given to people who are at least 60 years old and have a relapse of their disease and who cannot receive other cancer medications.
The brand name Atripla is discontinued, but generic versions may be available.
Side effects of Dovato that are different from Atripla include low platelet counts (thrombocytopenia), low white blood cell counts (neutropenia, leukopenia), infection, anemia, fatigue, bleeding, febrile neutropenia, increased transaminases, abdominal pain, swelling and sores inside the mouth, increased gamma-glutamyltransferase, and too much bilirubin in the blood.
Side effects of Atripla that are different from Dovato include dizziness, anxiety, depression, sleep problems (insomnia), shortness of breath, high or low blood pressure, high blood sugar, and low blood oxygen.
Dovato may interact with drugs known to prolong the QT interval or induce Torsades de Pointes.
Atripla may interact with "live" vaccines, other chemotherapy treatments, antibiotics, antifungals, antidepressants, anti-malaria medicines, asthma inhalers, antipsychotic medicines, certain HIV/AIDS medicines, heart or blood pressure medicines, and medicines to prevent vomiting.
What Are Possible Side Effects of Dovato?
Common side effects of Dovato include:
- fatigue, and
What Are Possible Side Effects of Atripla?
Common side effects of Atripla include:
- trouble sleeping,
- unusual dreams, and
- trouble concentrating.
Side effects may begin 1-2 days after starting Atripla and usually go away in 2-4 weeks. Other side effects of Atripla include:
- upset stomach,
- diarrhea, and
- skin discoloration (such as small spots/freckles, darkening of the palms of the hands/soles of the feet), and
- changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and waist).
Tell your doctor if you have serious side effects of Atripla including:
- unexplained weight loss,
- persistent muscle aches or weakness,
- joint pain,
- numbness or tingling of the hands/feet/arms/legs,
- severe tiredness,
- vision changes,
- severe or persistent headaches,
- signs of infection (such as fever, chills, trouble breathing, cough, non-healing skin sores),
- signs of an overactive thyroid (such as irritability, nervousness, heat intolerance, fast/pounding/irregular heartbeat, bulging eyes, unusual growth in the neck or thyroid known as a goiter), or
- signs of a certain nerve problem known as Guillain-Barre Syndrome (such as difficulty breathing/swallowing/moving your eyes, drooping face, paralysis, slurred speech).
What Is Dovato?
Dovato (dolutegravir and lamivudine) is a combination of an integrase strand transfer inhibitor (INSTI) and a nucleoside analogue reverse transcriptase inhibitor (NRTI) indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known substitutions associated with resistance to the individual components of Dovato.
What Is Atripla?
Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate) is an antiviral medication that treats HIV, which causes acquired immunodeficiency syndrome (AIDS). Atripla is not a cure for HIV or AIDS.
What Drugs Interact With Dovato?
Dovato may interact with other antiretroviral drugs for the treatment of HIV-1 infection, dofetilide, metformin, anticonvulsants, rifampin, St. John's wort, cation-containing antacids or laxatives, sucralfate, buffered medications, oral calcium and iron supplements (including multivitamins containing calcium or iron), and sorbitol.
What Drugs Interact With Atripla?
Atripla (efavirenz, lamivudine and tenofovir disoproxil fumarate) is a three-drug combination of a non-nucleoside reverse transcriptase inhibitor, and two nucleo(t)side reverse transcriptase inhibitors indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 40 kg.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Gilead. Atripla Prescribing Information.